Cardiol Therapeutics Inc. Closes the Market
28 Enero 2019 - 12:30PM
PR Newswire (Canada)
TORONTO, Jan. 25, 2019 /CNW/ - David Elsley, President & CEO, Cardiol
Therapeutics Inc. (CRDL), joined Loui
Anastasopoulos, President, Capital Formation, Toronto Stock
Exchange & TSX Venture Exchange, to close the market. Cardiol
Therapeutics is a biotechnology company specializing in the
research and commercial development of pharmaceutical cannabidiol
products and targeted therapies for heart failure and cancer.
Cardiol Therapeutics Inc. commenced trading on Toronto Stock
Exchange on December 20, 2018.
SOURCE TMX Group Limited
Copyright 2019 Canada NewsWire
Cardiol Therapeutics (TSX:CRDL)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Cardiol Therapeutics (TSX:CRDL)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024